Lachman Consultant: With over 40% of compounders inspected receiving Warning Letters and nearly 100% receiving critical observations, can this industry respond effectively and meet FDA expectations? List of top ten violations

http://www.lachmanconsultants.com/2015/09/fda-is-diving-deeper-in-gmp-compliance-for-compounding-pharmacies-a-follow-up/